GDS Wealth Management
Source: SEC Form 13F · as of Mar 2026GDS Wealth Management holds 10 biotech & pharma companies tracked by BioSniper, totaling $27.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$27.4M
| Company | Shares | Value |
|---|---|---|
| IQVIQVIA Holdings Inc. | 98,388 | $16.8M |
| LLYELI LILLY & Co | 7,607 | $7.0M |
| ABBVAbbVie Inc. | 4,645 | $1.0M |
| JNJJOHNSON & JOHNSON | 3,360 | $821K |
| ABTABBOTT LABORATORIES | 4,683 | $481K |
| PMPhilip Morris International Inc | 2,465 | $408K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,206 | $326K |
| MCKMcKesson Corporation | 325 | $281K |
| MRKMerck & Co., Inc. | 1,682 | $202K |
| BTMDbiote Corp. | 42,789 | $58K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.